Clinical Trial Update: Decitabine in Treating Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

This Phase 2 trial update reports results of decitabine in adults with previously untreated acute myeloid leukemia, including patients across several cytogeneti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Untreated Acute Myeloid Leukemia

Drugs mentioned

• Decitabine (Decitabine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q) | Phase 2 | Status: COMPLETED | Results posted: 2016-06-27